IRDES PUBLICATIONS BY THEMES

MEDICINES/MEDICAL GOODS: CONSUMPTION - REGULATION

Questions d'économie de la santé (Issues in Health Economics)

How to Explain Price Gaps between Me-too Drugs?
A 2001-2009 Panel-data Analysis
Bergua L. (CHU de Rouen), Cartier T. (Université Paris Diderot, Sorbonne Paris Cité, Irdes), Célant N. (Irdes), Pichetti S. (Irdes), Sermet C. (Irdes), Sorasith C. (Irdes)
Issues in Health Economics (Questions d'économie de la santé) n° 178. 2012/07-08.

Analysis of the Impact of Drug Delisting in France between 2002 and 2011
Pichetti S., Sermet C.
Issues in Health Economics (Questions d'économie de la santé) n° 167. 2011/07-08.

Has the Introduction of Mandatory Deductibles Modified Patients’ Prescription Drug Purchasing Behaviour?
Kambia-Chopin B., Perronnin M.
Issues in Health Economics (Questions d'économie de la santé) n° 158. 2010/10

Group Practice Dynamics Among Private General Practitioners from 1998 to 2009
Baudier F. (ARS), Bourgueil Y. (Irdes), Evrard I. (Irdes), Gautier A. (Inpes), Le Fur P. (Irdes), Mousquès J. (Irdes)
Issues in Health Economics (Questions d'économie de la santé) n° 157. 2010/09

Drug-prescription Management in Patients with Multiple Chronic Conditions
Clerc P., Le Breton J., Mousquès J., Hebbrecht G., de Pouvourville G.
Issues in Health Economics (Questions d'économie de la santé) n° 156. 2010/07-08

The 2006 Health, Health Care and Insurance Survey, a Panel for Health Policies Analysis, Public Health and Health Economics Research.
Allonier C., Dourgnon P., Rochereau T.
Issues in Health Economics (Questions d'économie de la santé) n° 131. 2008/04

Delisting of Mucolytics and Expectorants: What is the Impact on General Practitioners’ Prescribing?
Devaux M., Grandfils N., Sermet C.
Issues in Health Economics (Questions d'économie de la santé) n° 128. 2007/12

The politics of drug reimbursementin England, France and Germany.
N'Guyen L., Or Z., Paris V. , Sermet C.
Issues in Health Economics (Questions d'économie de la santé) n° 99. 2005/10

Working papers

Entry Time Effects and Follow-on Drugs Competition
Andrade L.F. (Gate-Groupe d’analyse théorique et économique, Lyon ; Irdes)
Working paper n° 49. 2012/06
Abstract

Evolution 1998-2002 of the antidepressant consumption in France, Germany and the United Kingdom.
Grandfils N., Sermet C.
Working paper n° 21, 2009/02
Abstract

A refutation of the practice style hypothesis: the case of antibiotics prescription by French general practitioners for acute rhinopharyngitis.
Mousquès J. (Irdes) Renaud T. (Irdes) Scemama O. (HAS)
Working paper n° 18, 2008/10
Abstract
Published in...

Drug price setting and regulation in France.
Grandfils N.
Working paper n° 16, 2008/09
Abstract
Published in...

Reports

French Health, Health Care and Insurance Survey 2006 (ESPS 2006)
Allonier C., Dourgnon P., Rochereau T. Irdes report. 2008/04, 238 pages.
English abstract
Executive summary - Questions d'économie de la santé n° 131

The politics of reimbursement of pharmaceuticals in England, France and Germany.
Nguyen-Kim L., Or Z., Paris V., Sermet C., Irdes report, 2005/11. 54 pages.
English abstract
Executive summary - Questions d'économie de la santé n° 99

The prescription of medications providing insufficient therapeutic value in 2001
Naudin F., Sermet C. Irdes report, 2004/07, 110 pages.
English abstract

Medical practice variability in primary care: the prescription of antibiotics for acute rhinopharyngitis
Mousquès J., Renaud T. (Irdes), Scemama O. (Dép. de santé publique UFR Broussais Hôtel-Dieu). Irdes report, 2003/08, 112 pages.
English abstract

Publications by Irdes researchers in other venues

Dabigatran – a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs.
Malmström R.E., Godman B.B., Diogene E., Baumgärtel C., Bennie M., Bishop I., Brzezinska A., Bucsics A., Campbell S., Ferrario A., Finlayson A.E., Fürst J., Garuoliene K., Gomes M., Gutiérrez-Ibarluzea I., Haycox A., Hviding K., Herholz H., Hoffmann M., Jan S., Jones J., Joppi R., Kalaba M., Kvalheim C., Laius O., Langner I., Lonsdale J., Lööv S.Å., Malinowska K., McCullagh L., Paterson K., Markovic-Pekovic V., Martin A., Piessnegger J., Selke G., Sermet C., Simoens S., Tulunay C., Tomek D., Vončina L., Vlahovic-Palcevski V., Wale J., Wilcock M., Wladysiuk M., van Woerkom M., Zara C., Gustafsson L.L., Frontiers in pharmacology, vol 4, article 39, 2013/05, 1-31.
On Frontiers site

Multilevel Analysis of the Influence of Patients' and General Practitioners' Characteristics on Patented Versus Multiple-Sourced Statin Prescribing in France.
Pichetti S., Sermet C., Godman B., Campbell S.M., Gustafsson L.L., Applied Health Economics and Health Policy, en ligne, 2013/04, 1-14.
On Springer Link site

Essential to increase the use of generics in Europe to maintain comprehensive health care ?
Godman B., Bennie M., Baumgärtel C., Sovic-Brkicic L., Burkhardt T., Fürst J., Garuoliene K., Gomes M., Markovic-Pekovic V., Martin A., Sermet C., Skiold P., Van Woerkom M., Voncina L., Gustafsson L.L., Farmeconomia. Health economics and therapeutic pathways, 2012, vol 13, Suppl n°3S, 5-20.
On Farmeconomia site

European payer initiatives to reduce prescribing costs through use of generics.
Godman B., Wettermark B., Sermet C. et al., GaBi Journal : Generics and Biosimilars Initiative Journal, vol. 1, issue 1, 2012, 22-27.
On GaBi Journal site

What lessons can be learned from the launch of generic clopidogrel?
Baumgärtel C., Godman B., Malmstrom R.E., Andersen M., Abuelkhair M., Abdu S., Bennie M., Bishop I., Burkhardt T., Fahmy S., Furst J., Garuoliene K., Herholz H., Kalaba M., Koskinen H., Laius O., Lonsdale J., Malinowska K., Ringerud A.M., Schwabe U., Sermet C., Skiold P., Teixeira I., van Woerkom M., Vitry A., Vončina L., Zara C., Gustafsson L.L., Generics and Biosimilars Initiative Journal (GaBI Journal). vol 1, n°2, 2012, 58-68.
On GaBi Journal site

Payers endorse generics to enhance prescribing efficiency: impact and future implications, a case history approach.
Godman B., Abuelkhair M., Vitry A., Abdu S., Bennie M., Bishop I., Fahmy S., Garuoliene K., Herholz H., Martin A., Malmstrom R.E., Jan S., Schwabe U., Sermet C., Skiold P., Voncina L., Gustaffson L.L., Generics and Biosimilars Initiative Journal (GaBI Journal). vol 1, n°2, 2012, 69-83.
On GaBi Journal site

Analysis of the impact of removing mucolytics and expectorants from the list of reimbursable drugs on presciption rates: A time-series analysis for France 1998-2010.
Pichetti S., Sorasith C., Sermet C., Health Policy, vol.102, issues 2-3, 2011/10, 159-169.

Policies to enhance prescribing efficiency in Europe: findings and future implications.
Godman B., Shrank W., Andersen M., Berg C., Bishop I., Burkhardt T., Garuoliene K., Herholz H., Joppi R., Kalaba M., Laius O., Lonsdale J., Malmström R.E., Martikainen J.E., Samaluk V., Sermet C., Schwabe U., Teixeira I., Tilson L., Tulunay F.C., Vlahovic-Palcevski V., Wendykowska K., Wettermark B., Zara C., Gustafsson L.L., Frontiers in pharmacology, vol 1, article 141, 2011/01, 1-16.
On Frontiers site

Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization : changes seen and global implications.
Godman B., Shrank W., Andersen M., Berg C., Bishop I., Burkhardt T., Garuoliene K., Herholz H., Joppi R., Kalaba M., Laius O., McGinn D., Samaluk V., Sermet C., Schwabe U., Teixeira I., Tilson L., Tulunay F.C., Vlahović-Palčevski V., Wendykowska K., Wettermark B., Zara C., Gustafsson L.L., Expert Review of Pharmacoeconomics & Outcomes Research, vol 10, n°6, 2010/12, 707-722.
On Expert reviews site

Effect of a French experiment of team work between general practitioners and nurses on efficacy and cost of type 2 diabetes patients care.
Mousquès J., Bourgueil Y., Le Fur P., Yilmaz E., Health Policy, vol 98, n°2-3, 2010/12, 131-143.
On Health Policy site

Use of Generics - A Critical Cost Containment Measure for All Healthcare Professionals in Europe ?
Godman B., Shrank W., Wettermark B., Andersen M., Bishop I., Burkhardt T., Garuolienè K., Kalaba M., Laius O., Joppi R., Sermet C., Schwabe U., Teixeira I., Cankat Tulunay F., Wendykowska K., Zara C., L. Gustafsson L., Pharmaceuticals, vol 3, n°2, 2010, 2470-2494.
On MDPI site

Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers.
Adamski J., Godman B., Ofierska-Sujkowska G., Osinska B., Herholzl H., Wendykowska K., Laius O., Jan S., Sermet C., Zara C., Kalaba M., Gustafsson R., Garuoliene K., Haycox A., Garattini S., Gustafsson L.L., BMC Health Services Research, vol 10, n°153, 1-29, 2010/06.
On Biomedcentral site

Ongoing pharmaceutical reforms in France : Implications for Key Stakeholder Groups, Sermet C., Andrieu V., Godman B., Van Ganse E., Haycox A . , Reynier J.P., Applied Health Economics and Health Policy, vol 8, n°1, 2010, 7-24
Abstract

Pharmaceutical policy in France : a mosaic of reforms.Grandfils N., Sermet C., Eurohealth, 2006, vol.12, n° 3, 15-17.
Full text on the LSE site

Pharmaceutical regulation in France 1980-2003.Paris V., The International Journal of Health Planning and Management, 2005/11, 307-328.
Abstract

No significant decrease in antibiotic use from 1992 to 2000, in the French community. Sommet A., Sermet C., Boëlle P.-Y., Tafflet M., Bernède C., Guillemot D., In "Journal of Antimicrobial Chemotherapy" Vol 54, Edité par Oxford University Press, 2004, pp. 1-5.
Full text on Oxford Journals site

Changes in osteoarthritis management by general practitioners in the COX2-inhibitor era-concomitant gastroprotective therapy). Bouée S., Charlemagne A., Fagnani F., Le Jeunne P., Sermet C., Naudin F., Lancry P.-J., In « Revue du Rhumatisme », vol. 71, n° 5, 2004/05, pp. 378-385.
Abstract

More on the French Site...